- Home
- SPNT vs LGND Comparison
SPNT vs LGND Comparison
Compare SPNT & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPNT | LGND |
|---|---|---|
| Founded | 2011 | 1987 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 3.9B |
| IPO Year | N/A | 1992 |
Fundamental Metrics
Financial Performance| Metric | SPNT | LGND |
|---|---|---|
| Price | $21.15 | $186.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $24.00 | ★ $239.33 |
| AVG Volume (30 Days) | ★ 779.3K | 206.0K |
| Earning Date | 02-17-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.76 |
| EPS | 1.45 | ★ 2.49 |
| Revenue | ★ $2,859,100,000.00 | $251,233,000.00 |
| Revenue This Year | $0.89 | $52.87 |
| Revenue Next Year | $6.87 | $6.07 |
| P/E Ratio | ★ $15.06 | $75.92 |
| Revenue Growth | 6.92 | ★ 64.83 |
| 52 Week Low | $13.26 | $93.58 |
| 52 Week High | $22.89 | $212.49 |
Technical Indicators
Market Signals| Indicator | SPNT | LGND |
|---|---|---|
| Relative Strength Index (RSI) | 44.49 | 45.00 |
| Support Level | $22.00 | $194.44 |
| Resistance Level | $22.74 | $198.80 |
| Average True Range (ATR) | 0.50 | 5.54 |
| MACD | -0.18 | -0.42 |
| Stochastic Oscillator | 10.21 | 42.37 |
Price Performance
Historical ComparisonAbout SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.